Ash A. Alizadeh
Artificial Intelligence · 1879–2023
A researcher in the Science corpus: 24 papers; trusts 4 researchers and is trusted by 9 researchers here, as inferred from the citation graph.
Subfields
- Artificial Intelligence — 37 citations into it
- Statistics and Probability — 12 citations into it; #4,810 of 12,932 by trust here, #4,371 by citations
- Health Informatics — 7 citations into it
Whom Ash A. Alizadeh trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Hui Zou
- Robert Tibshirani
- Paul R. Rosenbaum
- R. Majeti
- Hugh A. Chipman
- Siddhartha Jaiswal
- Ying‐Qi Zhao
- Trevor J. Hastie
- Donald B. Rubin
- Cynthia Rudin
Who trusts Ash A. Alizadeh overall
- Susan Athey
- Chris H. Q. Ding
- Yanbo Xu
- Guido W. Imbens
- Atul J. Butte
- Sandrine Dudoit
- Robert Tibshirani
- Hanchuan Peng
- Lipo Wang
- Eric Bair
Papers from Ash A. Alizadeh's perspective
Ordered by how strongly the researchers Ash A. Alizadeh trusts endorse each paper. Same corpus, a different order for every researcher.
- Regression Shrinkage and Selection via the Lasso
- Attention is All you Need (Neural Information Processing Systems)
- The central role of the propensity score in observational studies for causal effects
- The Adaptive Lasso and Its Oracle Properties
- The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. (New England Journal of Medicine)
- Estimating Individualized Treatment Rules Using Outcome Weighted Learning
- Stem cells, cancer, and cancer stem cells (Nature)
- Identification of human brain tumour initiating cells (Nature)
- Integrin-associated protein (CD47) and its ligands. (Trends in Cell Biology)
- CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells (Cell)
Their papers
- A Simple Method for Detecting Interactions between a Treatment and a Large Number of Covariates (2012) — 388 citations
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (2000) — 10,272 citations
- 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns (2000) — 639 citations
- SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data (2003) — 457 citations
- CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells (2009) — 1,689 citations
- Robust enumeration of cell subsets from tissue expression profiles (2015) — 5,813 citations
- Toward understanding and exploiting tumor heterogeneity (2015) — 708 citations
- Determining cell-type abundance and expression from bulk tissues with digital cytometry (2019) — 3,625 citations
- Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia (2001) — 1,219 citations
- Individuality and variation in gene expression patterns in human blood (2003) — 844 citations
- Profiling tumor infiltrating immune cells with CIBERSORT (2018) — 3,139 citations
- From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment. (2023) — 507 citations
- Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx (2020) — 428 citations
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer (2020) — 1,007 citations
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling (2017) — 859 citations
- Integrated digital error suppression for improved detection of circulating tumor DNA (2016) — 974 citations
- Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers (2015) — 2,527 citations
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage (2014) — 2,063 citations
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors (2012) — 1,535 citations
- Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47 (2010) — 737 citations